Wegovy vs Mounjaro: Which Weight Loss Injection Suits You?
Weight Loss Injections UK: Wegovy vs Mounjaro Key Differences
When exploring weight loss injections in the UK, understanding the fundamental differences between Wegovy and Mounjaro can help inform your decision. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, while Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors for dual action. Wegovy follows a 5-dose escalation schedule from 0.25mg to 2.4mg maintenance over 16 weeks, whereas Mounjaro offers 6 dose levels from 2.5mg to 15mg. Both prescription-only medicines require clinical assessment and work alongside dietary changes and increased physical activity.
The storage requirements also differ significantly for these weight loss injections UK patients can access. Wegovy maintains stability for up to 6 weeks at room temperature once removed from the fridge, making it more convenient for travel compared to Mounjaro's 21-day room temperature limit. Both medications use pre-filled injection pens, but Wegovy's FlexTouch pen system has been refined over many years of use. At EverydayMeds, our clinical team can help you understand which option aligns better with your lifestyle and medical history through our comprehensive online assessment process.
Wegovy vs Mounjaro Pricing: Transparent Costs for UK Patients
Understanding the cost structure for weight loss injections UK patients require helps with treatment planning and budgeting. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenience, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, covering your first 8 weeks of treatment. New customers apply discount code FIRST40 at checkout, while returning patients use DOSE25 to reach these final prices.
Mounjaro follows a different pricing structure reflecting its dual-action mechanism and dosing schedule. Both weight loss injections UK patients can access through EverydayMeds come with the same high standard of clinical care and cold-chain delivery. Our Take-It-Slow bundles like the Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) for £269.99 accommodate patients who need extended time at lower doses. The Ultimate Stability Trio provides 3 months of maintenance supply at £649.99, ensuring treatment continuity. All prices include prescriber review and next-day temperature-controlled delivery once approved.
Clinical Evidence: STEP Trials and Weight Loss Outcomes
The clinical evidence supporting Wegovy as an effective option among weight loss injections UK patients can access comes primarily from the STEP trial programme. In the pivotal STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. STEP 5 demonstrated sustained weight loss of approximately 15.2% at 2 years, while STEP 3 showed approximately clinically studied weight loss when combined with intensive behavioural therapy.
The SELECT cardiovascular outcomes trial revealed an additional benefit, with Wegovy associated with a 20% reduction in major cardiovascular events (HR 0.80) in eligible patients. NICE has recommended Wegovy in guidance TA875 for weight management with specialist support, recognising its place among effective weight loss injections UK healthcare providers can prescribe. It's important to note that individual results may vary, and these outcomes were achieved alongside comprehensive lifestyle interventions including dietary changes and increased physical activity.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy's effectiveness as one of the leading weight loss injections UK patients can access stems from its action as a GLP-1 receptor agonist. The active ingredient semaglutide mimics a hormone naturally produced in your intestines called glucagon-like peptide-1, which signals fullness to your brain after eating. This mechanism may help reduce appetite and promote earlier satiety, meaning you feel satisfied with smaller portions. The medication works on appetite centres in the brain, potentially reducing food cravings and the desire to snack between meals. Unlike appetite suppressants that work through different pathways, Wegovy enhances your body's natural fullness signals rather than overriding them artificially.
Simple Ordering Process: From Assessment to Delivery
Accessing weight loss injections UK patients need through EverydayMeds follows a streamlined but thorough process designed for safety and convenience. Our 3-minute online clinical assessment covers your medical history, current medications, previous weight management attempts, and lifestyle factors to determine suitability. Once submitted, our prescribers review your information within 3 working days (or 24 hours with express service), ensuring each patient receives appropriate clinical oversight as required for prescription-only medicines. Upon approval, we dispatch your medication via next-day delivery using temperature-controlled cold-chain logistics to maintain product integrity. All weight loss injections UK patients receive include comprehensive injection guides and ongoing clinical support throughout their treatment journey.
Storage and Practical Considerations for Daily Use
Proper storage and handling ensure optimal effectiveness of your weight loss injections UK treatment, whether choosing Wegovy or Mounjaro. Wegovy must be stored in the fridge at 2-8°C before first use, but offers the advantage of remaining stable for up to 6 weeks at room temperature below 30°C once removed. The FlexTouch pen system requires no mixing or preparation — simply attach a new needle for each weekly injection and follow the dose escalation schedule. Dose escalation cannot be skipped and follows the mandatory progression: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, then 2.4mg for maintenance. The injection site should be rotated between thigh, abdomen, or upper arm to prevent tissue irritation, and the same day each week helps maintain consistent medication levels.
Wegovy vs Mounjaro: Making Your Decision
The choice between these two weight loss injections UK patients can access often depends on individual factors including medical history, lifestyle preferences, and response to treatment. Wegovy's longer room temperature stability makes it ideal for frequent travellers, while its established track record provides confidence for first-time users. The 5-dose escalation schedule may be simpler to manage compared to Mounjaro's 6-dose pathway. Both medications require the same commitment to dietary changes and increased physical activity for optimal outcomes.
At EverydayMeds, we recognise that selecting appropriate weight loss injections UK patients require involves careful consideration of multiple factors. Our prescribers evaluate your individual circumstances, including any contraindications, previous treatment responses, and lifestyle factors that might influence your choice. Both Wegovy and Mounjaro are available through our platform, ensuring you can access either option based on clinical suitability rather than availability constraints that affect other providers.
Start Your Weight Loss Journey Today
Ready to explore which of these weight loss injections UK patients trust might be right for you? EverydayMeds offers both Wegovy and Mounjaro with the same high standard of clinical care and convenient delivery service. New customers can apply discount code FIRST40 at checkout, while returning patients use DOSE25 for their preferred pricing. Our GPhC-registered pharmacy (#9012878) ensures all medications meet strict UK safety and quality standards. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover how our expert team can support your weight management goals with professional, confidential care tailored to your individual needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
